University of Wisconsin-Madison School of Medicine and Public Health
Madison, Wisconsin, 53726, United States
NCT Number: NCT03239717
Branched-chain amino acids (BCAAs) are essential nutrients that the body obtains from proteins found in food, especially meat, diary products, and legumes. Data from rodent studies suggest that reduction of dietary BCAAs will promote fat mass loss and improved control of blood glucose. The purpose of this study is to test if reduction of dietary BCAAs without reducing calorie intake will lead to similar metabolic benefits in humans. Here the investigators test the feasibility of reducing dietary BCAAs using BCAA-free meal replacement beverages for two months.
Looking for future studies?
Notify Me35 year–65 year
Male
Interventional
Not applicable
Madison, Wisconsin, 53726, United States
This study, which will be completed over three months, involves replacing two meals a day with meal replacement beverages for two months, with a one month follow-up visit. These beverages will be made up by subjects using either a complete protein powder or BCAD2, a BCAA-free medical food. Participants will complete food diaries at baseline and at one month intervals during the study, and compliance will be assessed via food diaries, weekly telephone contact, and measuring returned food powder.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants in the Control Arm will replace two-thirds of participants dietary protein intake with a commercially available whey protein powder.
Participants in the Experimental Arm will replace two-thirds of participants dietary protein intake with BCAD2 (Mead Johnson), a BCAA-free medical food.
Time frame: 3 months
The principle outcome of this study is to determine if replacing 2/3rds of the subjects baseline protein intake with BCAA-free meal replacement beverages are a feasible method of selectively reducing BCAA consumption. Our principle outcome is to reduce BCAA intake by 50% or more in the Experimental Arm (BCAD2) of the study as compared to baseline intake.
Time frame: 3 months
Weight in kg
Time frame: 3 months
Fat mass in kg
Time frame: 3 months
Weight in kg and height in meters will be combined to report BMI in kg/m^2
Time frame: 3 months
Resting metabolic rate in kcal/hour
Time frame: 3 months
Fasting blood glucose in mg/dL
Time frame: 3 months
Insulin in ng/dL
Time frame: 3 months
HbA1c in mmol/mol
Time frame: 3 months
Area under the curve in mg/dL/min
University of Wisconsin, Madison
Other
Acronym: SOAR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01809288
Behavior, Body Weight
Bethesda, Maryland, United States
View Trial DetailsNCT06697977
Body Weight, Diabetes
Amman, Jordan
View Trial DetailsNCT04392284
Body Weight, Cardiovascular Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT04420650
Body Weight, Diabetes
Tübingen, Germany
View Trial Details